Should JNJ Stock Be in Your Portfolio Ahead of Q3 Earnings?

Johnson & Johnson (JNJ) will report its third-quarter earnings on Oct. 15. The Zacks Consensus Estimate for sales and earnings is pegged at $22.19 billion and$2.19 per share, respectively. The Zacks Consensus Estimate for JNJ’s earnings has declined from $10.07 per share to$10.00 per share for 2024 and from $10.63 per share to$10.62 per share for 2025 over the past 60 days.JNJ Estimate MovementImage Source: Zacks Investment ResearchJNJ's Earnings Surprise HistoryThe healthcare bellwether’s performance ha ...